# Methylation Biosignature in Childhood Chronic Kidney Disease

> **NCT02022046** · — · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 69 (actual)

## Conditions studied

- Chronic Kidney Disease
- Cardiovascular Disease

## Interventions

- **OTHER:** Methylation biosignature

## Key facts

- **NCT ID:** NCT02022046
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022046, "Methylation Biosignature in Childhood Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02022046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*